<DOC>
	<DOCNO>NCT01147224</DOCNO>
	<brief_summary>The aim study evaluate efficacy Alvesco patient persistent asthma include exclude allergic component 3 month , especially spring season . Alvesco inhale metered-dose inhaler . The study provide data safety tolerability Alvesco .</brief_summary>
	<brief_title>ATEM ( Alvesco Non-interventional Study )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Asthma without allergic component Main Hypersensitive compound Alvesco Other criterion define Summary Product Characteristics , Chapter 4.3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Allergy</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Alvesco</keyword>
	<keyword>Inhaled steroid</keyword>
</DOC>